Exploring the Recent Developments in Gene Therapy for Glomerular Diseases
Time: 1:30 pm
day: Pre-Conference Focus Day
Details:
- Examine recent advancements in gene therapy for glomerular diseases, focusing on novel vector technologies and targeted delivery systems designed to restore kidney function by addressing the underlying genetic drivers of disease
- Explore PureSpring Therapeutics’ innovative approach using adeno-associated virus (AAV) vectors to enable precision targeting of podocyte-specific pathways, highlighting its potential to revolutionize treatment for glomerular disorders
- Review preclinical and translational data supporting the feasibility and safety of gene therapies in glomerular diseases, emphasizing their promise in transforming care paradigms for high-burden, unmet medical needs